Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444
Published February 26, 2020 · Recall initiated: December 18, 2019
Summary
FDA records medical device Class II recall Z-1233-2020, published February 26, 2020 and initiated December 18, 2019. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 11,725 units; Lot: UDI Number: 00842768036262 Lots: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- US Nationwide
- Lot
- UDI Number: 00842768036262 Lots: All lots
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDANC TRAVELER Coronary Dilatation Catheter, REF 1013158-08, Rx Only,NC Traveler RX 4.5 X 8MM The NC Traveler RXFebruary 26, 2020
- FDAMedicrea International Universal Counter Torque for use with the Pass TULIP [Spinal] System Ref : A22020500February 26, 2020
Questions about this recall
Was Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444 recalled?
Yes. FDA published recall Z-1233-2020 on February 26, 2020. Reported hazard: There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.
What should I do if I have this product?
Voluntary: Firm initiated · Letter